Federal award
SAREPTA THERAPEUTICS, INC.
HDTRA110C0079
Contract
Obligated and Ceiling
- Obligated (net)
- $12,324,640.64
- Ceiling (potential value, not spending)
- $13,092,616.75
- Current value
- $13,092,616.75
- Gross positive obligations
- $13,229,616.55
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- SAREPTA THERAPEUTICS, INC. · YKM9HZ3EH6X1
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- SAREPTA THERAPEUTICS, INC. · FVMHHCGQKM83
- Awarding agency
- Department of War · sub-agency 9761 · office HDTRA1
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AD92 · R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- HDTRA110C0079
- Award type code
- D
- Actions
- 11 · Jun 24, 2010 to Apr 27, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 27, 2018 | FY2018 | P00009 | M | $136,999.80 | — |
| Sep 8, 2017 | FY2017 | P00008 | C | −$136,999.80 | — |
| Mar 14, 2012 | FY2012 | P00007 | C | −$767,976.11 | — |
| Apr 28, 2011 | FY2011 | P00006 | C | $92,616.75 | — |
| Apr 14, 2011 | FY2011 | P00005 | B | $0.00 | — |
| Apr 8, 2011 | FY2011 | P00004 | C | $700,000.00 | — |
| Apr 1, 2011 | FY2011 | P00003 | C | $2,300,000.00 | — |
| Mar 3, 2011 | FY2011 | PZ0001 | H | $0.00 | — |
| Dec 14, 2010 | FY2011 | P00002 | M | $3,000,000.00 | — |
| Jun 29, 2010 | FY2010 | P00001 | M | $0.00 | — |
| Jun 24, 2010 | FY2010 | 0 | — | $7,000,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.